Webinar: Future Care Web Summit 2020

  • Sale
  • Regular price $360.00

Webinar: Thursday, January 23, 2020, at 1:00 PM - 2:30 PM Eastern

  • Forces of Change: The Future of Healthcare into 2040
  • The Legal, Regulatory and Policy Landscape for 2020
  • Social Determinants of Health Program & Policy Developments for 2020
  • On-Demand Sessions: Transformation Through Digitally Enabled Care, MSSP Pathways to Success

Webinar Faculty: Andrew Davis, FSA, MAAA, Principal, Deloitte Consulting; Mark E. Lutes, Chair, Board of Directors; Member of the Firm, Epstein Becker Green; Rose Englert, Principal Consultant, TCB Strategy

On-Demand Faculty: Molly Coye, MD MPH, Executive-In-Residence, AVIA Health; Colleen Norris, FSA, MAAA, Consulting Actuary, Milliman; Jason McEwen, FSA, MAAA, Consulting Actuary, Milliman

Need a Printable Form? Download a registration form you can fax or mail

MCOL Premium members are entitled to free registration to the annual Future Care Web Summit and receive a 50% discount on all other Healthcare Web Summit events. Members can email pattyj@mcol.com office to register for this event. Non-members can learn about MCOL Premium memberships and sign-up for free registration for this event and get a 50% discount on future Healthcare Web Summit events. 


What does the coming year and new decade hold for healthcare? What are the key healthcare business issues and trends for 2020 that will impact you and your organization, and how can you best position for them? Attend this web summit event and get 2020 vision for your healthcare organization. The Eighteenth Annual Future Care Web Summit addresses key future trends and also focuses on several important cutting-edge healthcare business topics.

Andy Davis, a Principal at Deloitte Consulting takes us on a healthcare journey through the next twenty years, in which the future of health will likely be driven by digital transformation enabled by radically interoperable data and open, secure platforms. Health is likely to revolve around sustaining well-being rather than responding to illness. While today, the US health care system is a collection of disconnected components (health plans, hospital systems, pharmaceutical companies, medical device manufacturers); by 2040, Deloitte expects the consumer will be at the center of the health model. Interoperable, always-on data will promote closer collaboration among industry stakeholders, and new combinations of services will be offered by incumbents and new entrants (disruptors). Interventions and treatments are likely to be more precise, less complex, less invasive, and cheaper.

Noted national healthcare expert speaker Mark Lutes, the Chair of Epstein Becker Green, will be discussing the healthcare legal, regulatory and policy landscape for 2020. The election year healthcare agenda, the plethora of CMS value based care initiatives, the continuing political target on the back of pharmaceutical pricing, and a host of other factors will weigh in to make 2020 a most active and interesting year indeed.

As we enter 2020, Social Determinants of Health have taken center stage, not only for Medicaid and Medicare populations with public and health plan initiatives, but also for the patient populations and communities served by health systems and provider networks. Rose Englert, Principal Consultant at TCB Strategy and a noted SDoH expert will provide an update on the Social Determinants of Health Program & Policy Developments for 2020.

What's more, the Future Care Web Summit offers two on-demand video faculty sessions covering: Transformation Through Digitally Enabled Care and The Journey Ahead on MSSP Pathways to Success.

Get 2020 healthcare vision and position yourself for the new decade by attending the Eighteenth Annual Future Care Web Summit. The event includes a featured 90 minute live webinar, two additional faculty on-demand video sessions plus supplemental features addressing key business trends and issues for 2020 and beyond.

Webinar Agenda

Thursday, January 23, 2020
1:00 p.m. to 2:30 p.m. Eastern (10:00 a.m. - 11:30 a.m. Pacific)
Click here to find out what time your event starts in your time zone.

  • 1:00 pm - 1:30 pm  Forces of Change: The Future of Healthcare into 2040 - Andrew Davis, FSA, MAAA, Principal, Deloitte Consulting
  • 1:30 pm - 2:00 pm  The Legal, Regulatory and Policy Landscape for 2020 -- Mark E. Lutes, Chair, Board of Directors; Member of the Firm, Epstein Becker Green
  • 2:00 pm - 2:30 pm  Social Determinants of Health Program & Policy Developments for 2020 - Rose Englert, Principal Consultant, TCB Strategy

On-Demand Sessions & More

On-Demand faculty video presentations:

  • Transformation Through Digitally Enabled Care: AVIA Health Innovation Initiatives & Research - Molly Coye, MD, MPH, Executive-In-Residence, AVIA Health (48 minutes)
  • The Journey Ahead on MSSP Pathways to Success: Milliman Final Rule Analysis and Implications - Colleen Norris, FSA, MAAA, Consulting Actuary, Milliman and Jason McEwen, FSA, MAAA, Consulting Actuary, Milliman (61 minutes)

Plus other Web Summit features including a Future Care Article Library, and an exclusive Future Care e-poll

Cure for the Common Webinar

In addition to the main faculty presentation, this event includes a fun whiteboard drawing format opening video, a brief moderated faculty interview, and concluding live audience questions and answers. The day before the event, you'll receive login information, including downloadable companion presentation slides.

Just after the event, you'll receive a follow-up request for feedback, also offering an opportunity to provide any final questions that can be forwarded to the faculty. Also, if you need support before, during or after the event, you can contact HealthcareWebSummit staff at any time.

Learning Objectives

After attending this webinar, attendees will be able to:

  • Explore key trends impacting the future of healthcare over the next twenty years
  • Gain a sense of the critical legal, regulatory and policy issues impacting healthcare in 2020
  • Ascertain the implications of Social Determinants of Health program and policy developments for 2020
  • Receive briefings on key 2019 topics including Transformation Through Digitally Enabled Care and The Journey Ahead on MSSP Pathways to Success
  • Engage in interactive learning through online question submission, attendee feedback and opportunity for post-event follow up questions.

Who Should Attend

Interested attendees would include:

  • C-Suite Executives, and Administrative staff
  • Legal, Government Relations and Regulatory executives and staff
  • Strategic, Planning, and Policy executives and staff
  • Transformation, Integration and Innovation executives and staff
  • Social Determinants of Health executives and staff
  • Population Health executives and staff
  • Medical Directors
  • Sales, Marketing and Business Development executives
  • Operations executives
  • Business Intelligence, Analyst and Research executives and staff
  • Provider Networks Executives and staff
  • Consultants and other interested parties

 Attendees would represent organizations including:

  • Health Plans and Insurance Companies
  • Hospitals and Health Systems
  • Life Sciences Organizations
  • Provider Networks
  • Medical Groups
  • Accountable Care Organizations
  • Community Based Organizations
  • TPAs and Employers
  • Associations, Institutes and Research Organizations
  • Government Agencies
  • Care Management Organizations
  • PBMs
  • Solutions Providers and Vendors
  • Financial Institutions
  • Media and other interested organizations


    Individual Registration Fee: $295. Post-event materials, with video of slides synchronized with speaker audio, plus presentation pdf file: $45 for attendees; $360 for non-attendees after the event. Register above or download a registration form.

    You can also register by phone: 209.577.4888. Corporate Site licensing also available. We look forward to your attendance!


    Andrew Davis

    Andrew Davis, FSA, MAAA
    Deloitte Consulting

    Andrew Davis is a Principal in Deloitte Consulting LLP’s healthcare practice with over 15 years of experience and is a Fellow of the Society of Actuaries. He has been active in the space of healthcare transformation in recent years, working through as a leader through strategic decisions related to the Affordable Care Act, value based care and innovative contracting between payers, providers, and life sciences companies, and Deloitte’s Future of Health perspective.

    Andy works across the health care landscape including work with national and regional health plans, including multi-state BCBS plans, hospitals and provider groups, integrated delivery systems, large pharmaceutical companies, MedTech, and PBMs. He has experience across Commercial, Medicare, and Medicaid.

    Andy commonly brings teams aligned to strategic initiatives including pricing and profitability assessments, underwriting optimization, payment modeling, value-based care modeling, health care reform strategy, and network development and strategy.

    Mark E. Lutes

    Mark E. Lutes
    Chair, Board of Directors;
    Member of the Firm
    Epstein Becker Green

    Mark E. Lutes is a Member of the Firm in the Health Care and Life Sciences practice of Epstein Becker Green and the Chair of the firm's Board of Directors. Based in Washington, DC, he has practiced with the firm for nearly three decades. Prior to that, he was a legislative adviser to the Federal Trade Commission. He also offers strategic counsel in health policy and on reimbursement strategy through the firm's affiliates EBG Advisors, Inc., and National Health Advisors, LLC. 

    Mr. Lutes is a leader in the firm's representation of private equity and financial services firms with health care companies in their portfolios. He routinely deploys multidisciplinary teams of attorneys, reimburseme nt specialists, engineers, and scientists to assess the reimbursement, FDA and other domestic and international regulatory approvals, fraud and abuse compliance, CMS and legislative landscapes and other issues impacting proposed client investments in health care companies. Mr. Lutes combines experience with the corporate aspects of transactions with his deep experience in health care compliance issues to provide clients with practical advice in the negotiation of warranty and indemnification issues and in assessing risk factors in health and life science deals. He has advised on the largest transactions in the health care market including services, pharmaceutical and device companies. 

    Mr. Lutes is also an experienced antitrust counselor to health care companies contemplating mergers or acquisitions and has facilitated the antitrust clearance of numerous significant hospital mergers. He has managed the defense of high profile healthcare antitrust actions by the FTC.

    Mr. Lutes has a deep understanding of managed care markets and regulation. He is consulted by a variety of providers and payors in structuring innovative payment arrangements. Additionally, he counsels on hospital and physician ventures and compliance issues and in the area of information privacy and security. Mr. Lutes has developed privacy and security audit tools which support client compliance needs.

    He has been selected for inclusion in Washington, DC Super Lawyers (2007 to 2010, 2013, 2014) and honored by Nightingales as a leading health care antitrust lawyer. He is ranked among the "Leaders in Their Field" by Chambers USA (2010 to 2014). 

    Mr. Lutes is active in his parish and serves as Chair of the Advisory Board of the Spanish Catholic Center, a social and health services nonprofit. He also serves on the President's Council of Catholic Charities, Archdiocese of Washington, DC, which honored him with The Caritas Award, its highest recognition of volunteers. Mr. Lutes also has over a decade of service in leadership in the Boy Scouts of America organization.

    Rose Englert

    Rose Englert
    Principal Consultant
    TCB Strategy

    Rose Englert is an independent strategy, policy, and regulatory affairs consultant with nearly 20 years’ healthcare industry experience. She specializes in developing actionable plans to navigate Medicaid transformation, establish sustainable social determinants of health partnerships, and improve regulatory environments for organizations engaged with publicly funded health and social services.

    Prior to consulting, Ms. Englert was employed by the Medicare Advantage/D-SNP and Medicaid services organization CareOregon, where she built one of nation’s first, dedicated social determinants teams within a health plan. Under her direction, the Community Health Innovations department developed targeted interventions assisting high-risk patients address their needs related to housing, curative nutrition, social connection, and transportation. The partnership, data privacy, and Medicaid “flex” funding processes developed under Rose’s direction remain national models.

    Rose is an engaging speaker that has presented SDOH program and policy models to dozens of organizations nationwide, including the National Academy of Medicine, California Association of Health Plans, and JPAL Poverty Action Foundation at the MIT Department of Economics. She has served as faculty to the Institute for Healthcare Improvement and was retained as expert healthcare advisor to the U.S. Department of Housing and Urban Development. Rose has worked across the political aisles with local, state, and federal policymakers and 13 different state Medicaid agencies on behalf of various client interests.

    Rose lives with her daughter, dogs and cats in Portland, OR. In her free time, you will find her exploring the outdoors or researching ways to mitigate EHR silos and achieve Triple Aim goals through meaningful use adoption of artificial intelligence enabled tech platforms. Rose is nearing completion her Master of Healthcare (Administration) Leadership at Brown University.


    Dr. Molly Joel Coye

    Molly Coye, MD MPH
    AVIA Health

    Dr. Molly Joel Coye is an Executive-in-Residence at AVIA and a member of the board of directors of Aetna, Inc. From 2010-2015, Dr. Coye served as Chief Innovation Officer for UCLA Health and head of the Institute for Innovation at UCLA, where she led the health system in identifying new strategies, technologies, products and services to support the large-scale transformation of healthcare. Dr. Coye also advises technology developers, investors, national health systems, and policy makers about disruptive technologies and business models that accelerate transformation.

    From 1999-2010 Dr. Coye was Founder and CEO of the Health Technology Center, the premier forecasting organization for emerging technologies in healthcare. She has also served as Commissioner of Health for the State of New Jersey, Director of the California Department of Health Services, and Head of the Division of Public Health Practice at the Johns Hopkins School of Hygiene.

    An elected member of the National Academy of Medicine, Dr. Coye has been a board member of the American Hospital Association and the American Telemedicine Association, and chaired the board of the American Public Health Association and of PATH, one of the largest nonprofit organizations in global health.

    DColleen Norris

    Colleen Norris
    Consulting Actuary

    Colleen Norris is a consulting actuary with the Denver office of Milliman. She joined the firm in 2008. Colleen specializes in providing analytical and strategic support to organizations engaging in new models of reimbursing providers. She has helped both providers and payers develop quantitative approaches of understanding and measuring the spectrum of potential risk under a variety of potential arrangements. Colleen's experience includes analyzing changes to provider reimbursement contracts to ensure consistency with desires goals, modeling risk transfers in reimbursement contracts, and developing strategic approaches to manage transferred risks.

    She has assisted large provider systems with developing models for the appropriate transfer of financial risk to smaller provider units of providers, as well as has provided strategic and tactical planning for provider systems looking to optimize their long-term prospects in the era of increased risk-sharing. 

    She also has experience with Medicare ACO (MSSP & Next Gen) and MACRA risk impact assessments and strategic planning.

    Colleen has experience with using predictive models to help organizations identify, measure, and monitor key risk factors. Her background also includes commercial healthcare benefit plan design, pricing, feasibility studies, and financial modeling. She has developed regulatory filings for health carries, developed underwriting and rating models, and has projected liabilities for incurred but not paid claims.

    Colleen is a Fellow in the Society of Actuaries and a Member in the American Academy of Actuaries. She received her BS (summa cum laude) in Physics from Creighton University, and a MS in Physics, at the University of California, San Diego (UCSD).

    Jason McEwen

    Jason McEwen
    Consulting Actuary

    Jason McEwen is a consulting actuary with the Denver Health practice of Milliman. Jason assists provider organizations in navigating the ever-present world of value-based payments. He specializes in modeling and quantifying the risk associated with reimbursement contracts that differ from traditional fee-for-service arrangements. Jason has assisted provider organizations in determining the optimal Medicare ACO option to participate in and has evaluated the impact that different commercial ACO structures would have on the potential for shared savings.

    Jason also has experience in commercial pricing. This includes pricing self-funded, large group, small group, and individual products in multiple states. He has assisted various companies in developing strategic rates to best compete in the marketplace. He has also reviewed and helped improve rating action guidelines on small-group self-insured products.

    Jason’s background also includes many other areas of actuarial work, including projecting future risk adjustment payments on the exchange, projecting incurred but not reported claims, rate negotiations in Medicaid and USFHP programs, and Tricare bid development.

    Jason is a Fellow, Society of Actuaries, and a Member, American Academy of Actuaries. He received a BS in Actuarial Science, with a Business Management minor, from Brigham Young University.